Miyazaki, Yasuhiro http://orcid.org/0000-0002-8123-687X
Omori, Takeshi
Fujitani, Kazumasa
Fujita, Junya
Kawabata, Ryohei
Imamura, Hiroshi
Okada, Kazuyuki
Moon, Jeong-Ho
Hirao, Motohiro
Matsuyama, Jin
Saito, Takuro
Takahashi, Tsuyoshi
Kurokawa, Yukinori
Yamasaki, Makoto
Takiguchi, Shuji
Mori, Masaki
Doki, Yuichiro
,
Funding for this research was provided by:
the Supporting Center for Clinical Research and Education
Article History
Received: 17 December 2020
Accepted: 29 March 2021
First Online: 9 April 2021
Declarations
:
: YD has received lecture fees from Taiho Pharmaceutical, Chugai Pharmaceutical, Ono Pharmaceutical, Eli Lilly, MSD, Daiichi Sankyo, Yakult Honsha, Takeda Pharmaceutical, Kaken Pharmaceutical, Abbott Japan, Eisai, Shionogi, Otsuka Pharmaceutical, Ajinomoto Pharmaceutical, Teijin Pharma, Sanofi, Astellas Pharma, Tsumura, AstraZeneca, Asahi Kasei Pharma, Medtronic, Johnson & Johnson, Olympus, and Intuitive Surgical, Nippon Kayaku, Novartis Pharma, Pfizer Japan, CSL Behring, and Nestle. JM has received lecture fees from Chugai Pharmaceutical.
: Alinfol procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.
: Informed consent was obtained from all patients for inclusion in the study.
Free to read: This content has been made available to all.